| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 637.93M | 674.39M | 696.63M | 858.86M | 795.66M |
| Gross Profit | 94.13M | 74.24M | 95.27M | 125.33M | 123.93M |
| EBITDA | 27.06M | 7.01M | 30.29M | 43.73M | 41.21M |
| Net Income | 4.52M | -33.89M | -6.01M | 9.91M | 11.20M |
Balance Sheet | |||||
| Total Assets | 431.21M | 445.98M | 475.00M | 519.08M | 562.00M |
| Cash, Cash Equivalents and Short-Term Investments | 54.87M | 54.87M | 100.46M | 93.95M | 140.16M |
| Total Debt | 142.82M | 166.22M | 166.00M | 176.69M | 181.18M |
| Total Liabilities | 271.87M | 289.28M | 283.31M | 315.71M | 358.12M |
| Stockholders Equity | 158.70M | 155.95M | 190.67M | 206.47M | 201.46M |
Cash Flow | |||||
| Free Cash Flow | 29.91M | -21.03M | -5.01M | 8.81M | 47.38M |
| Operating Cash Flow | 31.59M | -18.13M | -1.29M | 20.26M | 56.47M |
| Investing Cash Flow | -1.06M | -84.00K | -908.00K | -10.23M | -7.49M |
| Financing Cash Flow | -31.09M | -3.29M | -15.65M | -12.91M | -15.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$17.83B | 10.91 | 14.30% | 5.87% | 6.88% | 11.98% | |
71 Outperform | HK$71.58B | 14.56 | 17.82% | 4.31% | 8.19% | -6.72% | |
67 Neutral | HK$2.40B | 4.54 | 8.52% | 4.00% | 3.40% | 151.24% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | HK$237.85M | 6.46 | -14.53% | ― | -5.61% | ― | |
60 Neutral | HK$1.71B | 2.40 | 2.58% | 9.71% | -7.47% | -33.28% | |
59 Neutral | HK$1.59B | 6.53 | 4.73% | 8.06% | -2.44% | -5.98% |